Neuro-affective Response to Light in Depressed Adolescents and Young Adults
2 other identifiers
interventional
80
1 country
1
Brief Summary
The goal of this neuroimaging pilot study is to understand developmental differences in the impact of therapeutic wavelength light (blue light) versus a non-therapeutic wavelength (red light) on emotional brain function in depression. The main questions this study aims to answer are:
- Does acute exposure to blue light (vs red light) stabilize emotional brain function in depressed individuals?
- Are stabilizing effects of blue light (vs red light) stronger for blue light in adolescents than young adults? Participants will complete:
- A magnetic resonance imaging brain scan, in which we will examine the effect of blue versus red light on emotional brain function at rest and in response to rewards and losses.
- A pupillometry test of sensitivity to blue vs red light
- Clinical interviews and surveys
- Screening measures for drug and alcohol use, MRI safety, and current pregnancy \[if relevant\]
- Home sleep tracking with sleep diary and actigraphy for one week
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2023
CompletedFirst Posted
Study publicly available on registry
February 3, 2023
CompletedStudy Start
First participant enrolled
June 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
August 11, 2025
August 1, 2025
3.1 years
January 25, 2023
August 5, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Amygdala cerebral blood flow during Blue vs Red light exposure
Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the amygdala region of interest will be examined.
Collected during the blue and red light exposures during the MRI scan at the lab visit
Ventral Striatum cerebral blood flow during Blue vs Red light exposure
Cerebral blood flow will be assessed using pseudo-continuous arterial spin labeling collected during blue and red light exposures. Regional cerebral blood flow in the ventral striatum region of interest will be examined.
Collected during the blue and red light exposures during the MRI scan at the lab visit
Amygdala activity (loss>neutral) during Blue vs Red light exposure
This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Activation is defined by blood oxygen dependent signal within an amygdala region of interest on loss versus neutral (no win/no loss) trials.
Collected during the blue and red light exposures during the MRI scan at the lab visit
Ventral Striatum activity (punish>neutral) during Blue vs Red light exposure
This outcome will be measured during the an auditory probabilistic reward task, which is a computerized fMRI behavioral task. Activation is defined by blood oxygen dependent signal within a ventral striatum region of interest on win versus neutral (no win/no loss) trials.
Collected during the blue and red light exposures during the MRI scan at the lab visit
Secondary Outcomes (9)
Medial prefrontal cortex cerebral blood flow during Blue vs Red light exposure
Collected during the blue and red light exposures during the MRI scan at the lab visit
Insula cerebral blood flow during Blue vs Red light exposure
Collected during the blue and red light exposures during the MRI scan at the lab visit
Ventromedial prefrontal cortex cerebral blood flow during Blue vs Red light exposure
Collected during the blue and red light exposures during the MRI scan at the lab visit
Amygdala-whole brain functional connectivity (loss>neutral) during Blue vs Red light exposure
Collected during the blue and red light exposures during the MRI scan at the lab visit
Ventromedial prefrontal cortex activity (loss>neutral) during Blue vs Red light exposure
Collected during the blue and red light exposures during the MRI scan at the lab visit
- +4 more secondary outcomes
Study Arms (2)
Blue then Red Light
EXPERIMENTALBlue light (480 nm) then Red light (640 nm)
Red Light then Blue Light
EXPERIMENTALRed light (640 nm) then Blue light (480 nm)
Interventions
Eligibility Criteria
You may qualify if:
- Elevated Depressive Symptoms \[PHQ9≥5 And (Item 1≥1 or Item 2≥1)\]
- (If \<18yr) Parent or guardian can attend the baseline clinical interview
You may not qualify if:
- Unable to read and write in English
- Intellectual disability.
- Left or mixed handedness
- Changes to psychotropic medication type or dosage in the past 2 months
- Lifetime bipolar disorder or schizophrenia, or substance/alcohol disorder in the past 3 months.
- Factors influencing light and color sensitivity (i.e., color-blindness, serious ophthalmological conditions, photo-sensitizing medication).
- Factors influencing the ability to maintain a stable sleep schedule (i.e., shift work, severe sleep disorders, extremely late or early sleep schedule).
- Severe medical illness, neurological disorders, or history of head trauma.
- Current pregnancy or nursing
- MRI contraindication (e.g., metals in the body, recent tattoo, claustrophobia)
- Positive alcohol or substance use screen at MRI visit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Western Psychiatric Hospital
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adriane M Soehner, PhD
University of Pittsburgh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 25, 2023
First Posted
February 3, 2023
Study Start
June 14, 2023
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
August 11, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Raw data and data from descriptive/raw measures will be submitted on a semi-annual basis by July 15 and January 15 or the next business day. We also agree to submit to NDA the analyzed data yielded in our project (i.e., 12 months after accomplishment of each primary aim or objective, or immediately upon publication of the project's primary results, whichever occurs first). The PIs reserve the right to publish on the stated aims in a timely manner during the period of the award. Data will be available for addressing other research questions (i.e. which are not described in funded/pending grants) as soon as the data have been checked for accuracy (a period which will be no later than one year after the completion of each assessment). After the award has ended, the study investigators will continue to test the stated aims, but will also continue to solicit collaborations with outside researchers and to consider data requests in a timely manner.
- Access Criteria
- Outside investigators must submit a 1) proposal of the study aims, hypotheses, variables/constructs, analytic approach, and estimated duration of the proposed research; 2) resume, qualifications, source of financial support, and conflict of interest statement; 3)sign a data-sharing agreement and confidentiality statement that stipulates using the data for the stated research purposes only, securing the data using appropriate computer technology, not manipulating the data in order to identify participants, acknowledging the grant that supported data collection and management in publications/presentations, and destroying or returning the data after analyses are complete; 4) obtain approval from their Institutional Review Board, and along with other staff members who have access to the data, submit certificates of human subjects protection training.
The investigators will complete and submit a National Data Archive (NDA) Data Sharing Agreement within 6 months of the Notice of Award Issue date. Study staff will upload data dictionary to the NDA website, and will review the NDA data definition for the measures collected and define the project's data definition harmonized to that standard. For measures not yet defined, project staff will work with the NDA staff to define the measure following NDA best practices. Informed consent will be collected from study participants that allows for broad sharing of participants' de-identified data. Study staff will use participants' personally identifiable information to generate NDA Global Unique Identifier (GUID) numbers for study participants. All data will be identified by GUID numbers only prior to submission to the NDA database. Data transfer procedures will be in accordance with all Institutional Review Board guidelines and federal regulations including HIPAA.